Status:
COMPLETED
Erciyes University Faculty of Health Sciences
Lead Sponsor:
TC Erciyes University
Collaborating Sponsors:
The Scientific and Technological Research Council of Turkey
Conditions:
Hemodialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sleep disorders are important to place among the symptoms frequently seen in hemodialysis patients. Among sleep disorders, restless legs syndrome is the most common. Restless legs syndrome, seen in pa...
Eligibility Criteria
Inclusion
- Those who are 18 years or older,
- Not pregnant and not planning a pregnancy,
- Having been diagnosed with restless leg syndrome according to the restless leg syndrome diagnostic scale and by a physician,
- Having at least mild restless leg syndrome according to the restless leg syndrome severity rating scale,
- Scoring 11 or above on the Epworth sleepiness scale,
- PSQI score an average of 5 and above,
- Receiving hemodialysis treatment in hemodialysis units for at least 3 months and 3 sessions per week,
- Continuing dialysis treatment in the same institution,
- Able to walk independently,
- No changes in the treatment program before the massage and throughout the research process,
- Not having any allergies to the oils to be used,
- Individuals who can understand and communicate with Turkish will be included in the research
Exclusion
- Those who are sensitive and/or have any allergies to the lavender oil to be used,
- Those who have lower leg problems that would prevent them from applying massage to the lower leg area,
- Have a history of mental or physical disability, including peripheral neuropathy, vascular problems in the legs,
- Epilepsy, Alzheimer's, Parkinson's, Multiple Sclerosis, etc. Those with a diagnosed neurological disease such as
- Pre-implemented,
- Those with respiratory system disorders,
- Patients who used other complementary and integrative therapies methods during the study period will be excluded from the study
Key Trial Info
Start Date :
December 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 12 2024
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06156930
Start Date
December 6 2023
End Date
June 12 2024
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erciyes University
Kayseri, Türkiye, Turkey (Türkiye), 38039